Description

Remozen V Tablet is a medicine that contains the active ingredient Remogliflozin. It is primarily used for the management of type 2 diabetes mellitus. Remogliflozin is an SGLT2 inhibitor that works by blocking glucose reabsorption in the kidneys, thereby aiding in the elimination of excess glucose through urine. By controlling blood glucose levels, Remozen V Tablet helps to reduce the risk of complications associated with diabetes, such as kidney damage, nerve problems, and heart diseases. It can also assist in weight management by promoting the loss of excess body weight. The dosage may vary depending on the patient’s medical condition and response to treatment. Patients should follow a balanced diet, exercise regularly, and monitor their blood sugar levels regularly while using Remozen V Tablet. It is important to consult a doctor before starting or discontinuing any medication.

Additional information